000 01362 a2200409 4500
005 20250517144939.0
264 0 _c20170608
008 201706s 0 0 eng d
022 _a1573-7225
024 7 _a10.1007/s10552-017-0888-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKwan, Marilyn L
245 0 0 _aPatterns and reasons for switching classes of hormonal therapy among women with early-stage breast cancer.
_h[electronic resource]
260 _bCancer causes & control : CCC
_cJun 2017
300 _a557-562 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAged
650 0 4 _aAntineoplastic Agents, Hormonal
_xadverse effects
650 0 4 _aAromatase Inhibitors
_xadverse effects
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCalifornia
650 0 4 _aDecision Making
650 0 4 _aDrug Substitution
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aTamoxifen
_xadverse effects
700 1 _aRoh, Janise M
700 1 _aLaurent, Cecile A
700 1 _aLee, Jean
700 1 _aTang, Li
700 1 _aHershman, Dawn
700 1 _aKushi, Lawrence H
700 1 _aYao, Song
773 0 _tCancer causes & control : CCC
_gvol. 28
_gno. 6
_gp. 557-562
856 4 0 _uhttps://doi.org/10.1007/s10552-017-0888-9
_zAvailable from publisher's website
999 _c27022407
_d27022407